172 related articles for article (PubMed ID: 8880755)
21. Prolonged analgesia after intracerebroventricular Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2).
Zadina JE; Kastin AJ; Kenigs V; Bruno C; Hackler L
Neurosci Lett; 1993 Jun; 155(2):220-2. PubMed ID: 8104325
[TBL] [Abstract][Full Text] [Related]
22. Interactions between the antiopiate Tyr-MIF-1 and the mu opiate morphiceptin at their respective binding sites in brain.
Zadina JE; Kastin AJ
Peptides; 1985; 6(5):965-70. PubMed ID: 2867527
[TBL] [Abstract][Full Text] [Related]
23. Characterization of binding sites for N-Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) in rat brain.
Zadina JE; Kastin AJ; Krieg EF; Coy DH
Pharmacol Biochem Behav; 1982 Dec; 17(6):1193-8. PubMed ID: 6131435
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of hematopoietic progenitor cell growth by Tyr-MIF, an endogenous opiate modulator, and its degradation products.
Horowitz D; Callahan JF; Pelus LM; Fukuda S; King AG
Int Immunopharmacol; 2002 Apr; 2(5):721-30. PubMed ID: 12013510
[TBL] [Abstract][Full Text] [Related]
25. Tolerance and morphine-induced cross-tolerance are not shown to Tyr-W-MIF-1 analgesia.
Bell RL; Vaccarino AL; Olson RD; Olson GA; Nores WL; Cambre JG; Zadina JE; Kastin AJ
Peptides; 1999; 20(8):971-8. PubMed ID: 10503776
[TBL] [Abstract][Full Text] [Related]
26. Structure-activity relationships of naturally occurring and synthetic opioid tetrapeptides acting on locus coeruleus neurons.
Yang YR; Chiu TH; Chen CL
Eur J Pharmacol; 1999 May; 372(3):229-36. PubMed ID: 10395016
[TBL] [Abstract][Full Text] [Related]
27. Tyr-MIF-1 attenuates antinociceptive responses induced by three models of stress-analgesia.
Galina ZH; Kastin AJ
Br J Pharmacol; 1987 Apr; 90(4):669-74. PubMed ID: 2884005
[TBL] [Abstract][Full Text] [Related]
28. Effects of neonatal treatment with Tyr-MIF-1, morphiceptin, and morphine on development, tail flick, and blood-brain barrier transport.
Harrison LM; Zadina JE; Banks WA; Kastin AJ
Brain Res Dev Brain Res; 1993 Oct; 75(2):207-12. PubMed ID: 7903224
[TBL] [Abstract][Full Text] [Related]
29. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
Sterious SN; Walker EA
J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
[TBL] [Abstract][Full Text] [Related]
30. Saturable brain-to-blood transport of endomorphins.
Kastin AJ; Fasold MB; Smith RR; Horner KA; Zadina JE
Exp Brain Res; 2001 Jul; 139(1):70-5. PubMed ID: 11482845
[TBL] [Abstract][Full Text] [Related]
31. Structural specificity of MIF-1 and Tyr-MIF-1 in augmenting GABA-stimulated benzodiazepine receptor binding.
Miller LG; Kastin AJ; Roy RB; Gaver A; Fischman AJ; Horvath A
Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):365-8. PubMed ID: 2908009
[TBL] [Abstract][Full Text] [Related]
32. Involvement of spinal mu1-opioid receptors on the Tyr-d-Arg-Phe-sarcosine-induced antinociception.
Mizoguchi H; Nakayama D; Watanabe H; Ito K; Sakurada W; Sawai T; Fujimura T; Sato T; Sakurada T; Sakurada S
Eur J Pharmacol; 2006 Jul; 540(1-3):67-72. PubMed ID: 16730704
[TBL] [Abstract][Full Text] [Related]
33. Regional differences in the metabolism of Tyr-MIF-1 and Tyr-W-MIF-1 by rat brain mitochondria.
Kastin AJ; Hahn K; Banks WA; Zadina JE
Biochem Pharmacol; 1998 Jan; 55(1):33-6. PubMed ID: 9413927
[TBL] [Abstract][Full Text] [Related]
34. Peptide transport system-1 (PTS-1) for Tyr-MIF-1 and Met-enkephalin differs from the receptors for either.
Maresh GA; Kastin AJ; Brown TT; Zadina JE; Banks WA
Brain Res; 1999 Aug; 839(2):336-40. PubMed ID: 10519058
[TBL] [Abstract][Full Text] [Related]
35. Antiopioid properties of the TYR-MIF-1 family.
Bocheva A; Dzambazova-Maximova E
Methods Find Exp Clin Pharmacol; 2004 Nov; 26(9):673-7. PubMed ID: 15632952
[TBL] [Abstract][Full Text] [Related]
36. Differential inhibitory effects of MIF-1, Tyr-MIF-1, naloxone and beta-funaltrexamine on body rotation-induced analgesia in the meadow vole, Microtus pennsylvanicus.
Lipa SM; Kavaliers M; Ossenkopp KP
Peptides; 1989; 10(3):493-7. PubMed ID: 2571138
[TBL] [Abstract][Full Text] [Related]
37. Tyr-MIF-1 acts as an opiate antagonist in the tail-flick test.
Kastin AJ; Stephens E; Ehrensing RH; Fischman AJ
Pharmacol Biochem Behav; 1984 Dec; 21(6):937-41. PubMed ID: 6151669
[TBL] [Abstract][Full Text] [Related]
38. Chronic, but not acute, administration of morphine alters antiopiate (Tyr-MIF-1) binding sites in rat brain.
Zadina JE; Kastin AJ; Ge LJ; Gulden H; Bungart KJ
Life Sci; 1989; 44(8):555-61. PubMed ID: 2564620
[TBL] [Abstract][Full Text] [Related]
39. Tyr-W-MIF-1 attenuates down-regulation of opiate receptors in SH-SY5Y human neuroblastoma cells.
Harrison LM; Kastin AJ; Zadina JE
J Pharmacol Exp Ther; 1998 Feb; 284(2):611-7. PubMed ID: 9454805
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of Tyr-MIF-1, MIF-1, and naloxone on peptide YY-induced hyperphagia.
Hagan MM; Moss DE
Peptides; 1994; 15(2):243-5. PubMed ID: 7911993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
